Convalescent Plasma for Outpatients with Covid-19

Convalescent Plasma for Outpatients with Covid-19

To the Editor In the Covid-19 Convalescent Plasma in Outpatients (C3PO) trial,1 Korley et al., members of the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN), administered convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19. It is unclear why the authors selected 1 week instead of a … Read more